Jefferies raised the price target for the Unitedhealth Group Inc (NYSE:UNH) stock from “a Hold” to “a Buy”. The rating was released on July 17, 2024, according to finviz. We previously noted in another research note published on July 17, 2024 by RBC Capital Mkts that reiterated the stock to an Outperform with a price target of $615 for UNH stock. The research report from HSBC Securities has upgraded the stock from Hold to Buy, with a price target set at $580. The stock was initiated by Robert W. Baird, who disclosed in a research note on May 30, 2024, to Outperform and set the price objective to $597. In their research brief published April 04, 2024, HSBC Securities analysts upgraded the Unitedhealth Group Inc stock from Reduce to Hold with a price target of $460.
The latest trade, Performances and Moving Averages give us the following Picture
The firm’s stock price fluctuated 2.34% within the last five trades and 14.96% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 11.93% in the last 6 months and 18.31% was added to its value over the previous 3 months. UNH stock is trading at a margin of 6.41%, 11.52% and 11.68% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Sponsored
As of the close of trading, UNH deals in the Healthcare domain. The stock is trading -1.50 percent below its 52-week high and 31.25 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 18.15. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Unitedhealth Group Inc’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 7.55 percent and the profit margin is 3.69 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $527.17 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Unitedhealth Group Inc (NYSE:UNH) is 37.96. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 18.38. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.38 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 6.08, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.19 percent of Unitedhealth Group Inc shares are owned by insiders, and 90.62 percent are held by financial institutions. McSweeney Erin, the EVP & Chief People Officer at Unitedhealth Group Inc (UNH) has sold 1,500 shares of firm on Jul 18 ’24 at a price of $579.03 against the total amount of $0.87 million. In another inside trade, ROOS THOMAS E, Chief Accounting Officer of Unitedhealth Group Inc (NYSE:UNH) sold 2,851 shares of the firm on Jul 17 ’24 for a total worth of $1.62 million at a price of $569.88. An inside trade which took place on Mar 08 ’24, EVP & Chief People Officer of Unitedhealth Group Inc McSweeney Erin sold 1,236 shares of firm against total price of $0.6 million at the cost of $483.48 per share.
